Skip to main content

Back to Cancer Australia's website

Australian Government - Cancer Australia
Home

Search form

EdCaN - learning resources for nurses

  • EdCaN learning resources
  • Professional development
  • About EdCaN
  • Contact us

Search form

  • Harvesting and storage
  • Conditioning
  • Transfusion
  • Engraftment and recovery
  1. EdCaN learning resources
  2. Supporting resources
  3. Stem cell transplantation
  4. The transplant process
  5. Transfusion of BM / PBSC
  • Printer-friendly version
  • A|A

Transfusion of BM / PBSC

  • Using the EdCaN resources
  • Case-based learning resources
  • Supporting resources
    • The cancer journey
    • Population health concepts
    • The biology of cancer
    • Cancer treatment planning
    • Surgery
    • Radiotherapy
    • Antineoplastic agents
    • Targeted therapies
    • Stem cell transplantation
      • Overview
      • Principles of transplantation
      • Sources of stem cells
      • Donor considerations
      • Recipient considerations
      • Bone marrow registries
      • Service delivery
      • The transplant process
      • Acute effects
      • Discharge
      • Chronic effects
      • Late effects
      • References
    • Supportive care
    • Aboriginal and Torres Strait Islander peoples
  • Entry to specialty program
  • Harvesting and storage
  • Conditioning
  • Transfusion
  • Engraftment and recovery

Stem cell infusion occurs on day 0. The recipient receives hydration and premedication according to their protocol, which may include:7

  • lorazepam
  • diphenhydramine hydrochloride
  • hydrocortisone
  • paracetamol
  • frusemide
  • methylprednisolone.

Frozen stem cells are thawed and quickly infused via a central venous access device. The recipient may experience a number of effects of the stem cell infusion related to the DMSO, lysis of red blood cells, volume of infusate and the coldness of the thawed cells:7

  • nausea and vomiting
  • haemoglobinuria
  • elevated serum creatinine
  • elevated serum bilirubin
  • cardiovascular effects
  • chills and fever
  • anaphylactic reaction.

Learning activities

Review an autologous transplant protocol and explain the rationale for processes on day 0 for the recipients.

Review an allogeneic transplant protocol and explain the rationale for processes on day 0 for the recipients.

Review your local protocol for stem cell infusion and conduct a teaching session with a novice nurse using the protocol.

Identify the signs and symptoms of anaphylactic reaction during stem cell infusion.

Discuss interventions to prevent and manage an anaphylactic reaction during stem cell infusion.

Outline the implications of a blood type incompatibility between the donor and recipient and interventions to reduce adverse effects in:

  • Minor ABO mismatch
  • Major ABO mismatch.

Outline your response as an SCN for a recipient who complains of 'black urine' six hours post stem cell infusion.

Next: Engraftment and recovery

  • Copyright © 2021 - Cancer Australia
  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy